Knowledge base · research
BPC-157 vs TB-500 — how they differ in research
BPC-157 and TB-500 are the two peptides most often discussed in the context of tissue regeneration research. They are frequently mentioned in the same breath, but they are different molecules with different origins. Below is a factual comparison — strictly within a research frame, with no guidance on use.
Origin and structure
BPC-157 is a synthetic peptide fragment derived from the sequence of a protein present in gastric juice. TB-500 is a synthetic counterpart of a fragment of thymosin beta-4 (Tβ4), a protein associated with cytoskeletal organisation. Different origins mean different mechanisms studied in the literature.
Areas of research
Both peptides appear in publications on regeneration models, but the context differs — BPC-157 often in models involving connective tissue and the gastrointestinal tract, TB-500 in the context of cell migration and the cytoskeleton. We have collected the literature overview for each separately: BPC-157 and TB-500.
What they share in laboratory practice
- A lyophilized form requiring reconstitution before use in research
- The need to verify quality through a batch COA (HPLC + mass spectrometry)
- Similar storage rules (powder refrigerated, solution roughly 4 weeks)
How to choose a source for either
Whichever peptide a given piece of research work involves, the criteria for choosing a supplier are the same: a COA for the specific batch, an SDS, a matching CAS number and a real company that issues an invoice. We have set them out in a separate guide: how to choose a supplier. Both materials are in the catalogue, with documentation.
Materials for research purposes only. Not for human or animal consumption. We do not advise on use.